Skip to main content

Leadership IS a geriatrics competency



by: Helen Chen, MD

Riding back to DFW on the airport shuttle after attending the Pioneer ACO presentations during the last session of the last day of #AGS13, I struck up a conversation with another attendee who is in private primary care practice. After learning that I am a PACE medical director, she responded, “What’s PACE?” I was surprised at the context, but not by the question. This is a conversation I have at least once a week in the community.

Invariably, after describing how the integrated, coordinated, PACE model of care serves frail , nursing home eligible, mostly dually eligible elders with the goal of helping them to remain in their communities as long as safely possible, most people I talk with want to know, “How can I get that for my mom, grandfather, (other older relative)?” Unfortunately, as many regular readers of GeriPal know, even though On-Lok began PACE in the early 70s, 40 years on, it is available in only 30 states, and serves a combined national panel size smaller than many FQHC systems in single states or regions. And, for elders with even modest resources, PACE is generally not obtainable because of financing or regulatory issues.

But the good news/bad news is that more recently, many health plans have taken notice. They are not waiting for the published results of various innovations or demonstration projects. Many large health systems are already looking to provide PACE-like “integrated and coordinated care” for their members, some of whom resemble the multimorbid, psychosocially complex elders cared for in PACE. Some ACOs are also beginning to bring some practical systems on line to address the needs of the complex elder. However, many of these decisions are being driven by economics: the financial incentives driving the management of adverse risk and reduction of hospitalizations and readmissions, among other outcomes.

The question is how many of us in the GeriPal world are in the boardrooms or the executive management meetings when these programs and systems are being created, or critical decisions are being made? We are a small tribe, but the very patients we care deeply about are going to have a lot of skin in this game. We need to effectively leverage our leadership abilities and skills. And, those of us who are directly involved in education need to prepare our fellows and other trainees to take on these leadership challenges which in the near term must include systems redesign and increased attention on “quality”. Otherwise, we will run the risk of continuing to be small islets of geriatrics excellence unable to influence much change in the choppy seas of “innovation” that may not adequately meet the needs of older adults, especially those who are the most complex.

by: Helen Chen, MD

Comments

Thank you Helen for your post, my thoughts echo yours, especially your last paragraph about "how many of us in the GeriPal world are in the boardrooms or the executive management meetings when these programs and systems are being created, or critical decisions are being made?"

I recently jotted down some similar thoughts about the need for physicians and clinicians to get involved in shaping the future of medicine:
http://www.medicineandtechnology.com/2013/05/the-physicians-evolving-role-in.html

Popular posts from this blog

Dying without Dialysis

There is a terrific article in this weeks Journal of Pain and Symptom Management by Fliss Murtagh of King's College in London about the epidemiology of symptoms for patients with advanced renal failure who die without dialysis.  This study is important because while we know that patients with advanced renal failure have a limited life expectancy and the average age of initiation of hemodialysis is increasing, we know little about the alternatives to hemodialysis.  Specifically, we know nothing about symptoms affecting quality of life among patients who elect not to start dialysis (so called "conservative management" - is this the best label?).  This article provides a terrific counterpoint to the article in last years NEJM showing that nursing home residents who initiated hemodialysis tended to die and decline in function (see GeriPal write up here). 

The study authors followed patients with the most advanced form of chronic kidney disease (the new name for renal failu…

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Language Matters: Podcast with Brian Block and Anna DeForest

One of our first GeriPal posts was titled "Rant on Terminology," by Patrice Villars, NP.  In the spirit of looking back over our first 10 years, here is the opening paragraph to that post:

News Headlines read: Sen. Edward Kennedy loses battle with cancer. Really, he lost? I thought he died from a malignant brain tumor, an “aggressive” brain tumor. The median survival is less than a year for people for his particular tumor. Kennedy was diagnosed in May of 2008. He lived over 15 months after diagnosis. What a loser. He must not have fought hard enough. Huh? I thought he spent most of his life battling for social and health care reform in America. In this week's GeriPal podcast we take a deeper dive into this issue of language and medicine.  We are joined by guests Anna DeForest, MD, MFA, a resident in Neurology at Yale, and Brian Block, MD, a pulmonary critical care fellow at UCSF.  

Anna recently published a paper in the NEJM describing her reaction to hearing terms like, &…